Skopos Labs, Inc. Regeneron Pharmaceuticals, Inc. Transaction History
Skopos Labs, Inc.
- $300 Million
- Q3 2024
A detailed history of Skopos Labs, Inc. transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Skopos Labs, Inc. holds 520 shares of REGN stock, worth $391,575. This represents 0.18% of its overall portfolio holdings.
Number of Shares
520
Previous 484
7.44%
Holding current value
$391,575
Previous $508,000
7.48%
% of portfolio
0.18%
Previous 0.23%
Shares
3 transactions
Others Institutions Holding REGN
# of Institutions
1,532Shares Held
84.1MCall Options Held
1.22MPut Options Held
1.51M-
Vanguard Group Inc Valley Forge, PA9.32MShares$7.02 Billion0.18% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$6.36 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY7.49MShares$5.64 Billion0.65% of portfolio
-
State Street Corp Boston, MA4.9MShares$3.69 Billion0.21% of portfolio
-
Capital World Investors Los Angeles, CA4.3MShares$3.24 Billion0.72% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $80.7B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...